Emmanuelle Tenório Albuquerque Madruga Godoi et al. Carlos Teixeira Brandt Heloisa Ramos Lacerda Jocelene Tenório Albuquerque Madruga Godoi … Dinaldo Cavalcanti de Oliveira Gabriela Farias Araujo Sousa Costa Gerson Gomes dos Santos Junior Kaliene Maria Estevão Leite Juannicelle Tenório Albuquerque Madruga Godoi Adriana Ferraz de Vasconcelos
Abstract
Background:
The prevalence of atherosclerosis is higher in HIV-positive people, who also experience it earlier than the general population.
Objectives:
To assess and compare the prevalence of atherosclerosis evaluated by the intima-media thickness of carotid and femoral arteries, and by the ankle-brachial pressure index (ABPI) in HIV patients treated or not treated with protease inhibitors (PIs) and controls.
Methods:
Eighty HIV+ subjects (40 using PIs and 40 not using PIs) and 65 controls were included in the study. Atherosclerosis was diagnosed by (carotid and femoral) ITM measurement and ABPI. Classical risk factors for atherosclerosis and HIV were compared between the groups by statistical tests. A p ≤ 0.05 was considered significant.
Results:
An IMT > P75 or the presence of plaque was higher in the HIV+ than in the control group (37.5% vs 19%, p = 0.04). Comparative analysis showed a significant difference (p=0.014) in carotid IMT between HIV+ with PIs (0.71 ± 0.28 mm), without PIs 0.63 ± 0.11 mm and, and controls (0.59 ± 0.11 mm). There was no significant difference in femoral IMT between the groups or in ABPI between HIV+ subjects and controls. However, a significant difference (p=0.015) was found between HIV+ patients not treated with PIs (1.17 [1.08 – 1.23]), and controls 1.08 [1.07 – 1.17]).
Conclusion:
In HIV patients, atherosclerosis is more prevalent and seems to occur earlier with particular characteristics compared with HIV-negative subjects.